Equities research analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research note issued on Monday. The firm set a “buy” rating on the stock.
Mannatech Stock Down 1.2 %
MTEX stock opened at $14.98 on Monday. The company has a current ratio of 1.25, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. The firm has a 50-day moving average of $10.63 and a two-hundred day moving average of $8.55. Mannatech has a 12 month low of $6.75 and a 12 month high of $15.83. The company has a market cap of $28.24 million, a price-to-earnings ratio of -18.49 and a beta of 1.04.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The company had revenue of $31.73 million for the quarter.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Recommended Stories
- Five stocks we like better than Mannatech
- Stock Average Calculator
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Buy P&G Now, Before It Sets A New All-Time High
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- What is a Dividend King?
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
